Index of Articles From AIDS Treatment News

2007

• Flu Shot Reminder (October 11, 2007)
• New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
• Isentress (Raltegravir) Pricing: Community Sign-On Letter (October 11, 2007)

2006

• Prezista (Darunavir, TMC-114) Approved; May Be Important Treatment Advance (June 29, 2006)
• Vaccine Improves Survival in Monkey Tests (June 29, 2006)
• XVI International AIDS Conference, Toronto, August 13-18, 2006; Record Number of Abstracts: India, Nigeria, South Africa, Brazil, Uganda Strongly Represented (June 29, 2006)
• AIDS History Research: New ArchiveGrid Available (June 29, 2006)
• Improving Medical Communication Online (June 29, 2006)
• Brain Drain Adds to AIDS Crisis in Developing World (June 29, 2006)
• Major UN Meeting, Major Demonstration This Week in New York (May 30, 2006)

• Issue #416, February 2, 2006
  1. Medicare Prescription Nightmare: Overview January 28, 2006
  2. FDA, Companies Test RFID Tracking to Prevent Drug Counterfeiting
  3. Buyers' Club List, December 2005

2005

• Issue #415, December 14, 2005
  1. TMC125: New Results, Large Phase III Trial Begins
  2. Integrase Inhibitors: First Clear Success in Human Trial
  3. CCR5 Entry Inhibitor Problems: No Clear Answers Yet
  4. Failure of Tenofovir + Abacavir + 3TC Combination; Full Report Published, More Insight
  5. XVI International AIDS Conference, August 2006 in Toronto; Deadlines Approaching; Reduced Registration Fees
  6. AIDS Vaccine History on PBS Documentary; DVD, Book Available
  7. Prison Health Crisis -- What You Can Do

• Issue #414, October 16, 2005
  1. Modern HIV May Be Slightly Less Virulent, Laboratory Study Suggests
  2. Major U.S. Treatment-Access Problems Likely: Inadequate Political Response
  3. Retroviruses Conference Deadlines Start October 2005
  4. One-Day HIV Treatment Meeting Near Boston, November 11
  5. HIV Treatment in Resource-Limited Settings: Call for Information
  6. Got Medicare? What People Living With HIV Need to Know About the New Medicare Drug Benefit -- "Part D" -- Starting January 1, 2006

• Issue #413, September 17, 2005
  1. Katrina: Disaster Notes
  2. Medicare HIV Fact Sheet: Caution re January 2006
  3. PA-457, New Kind of Antiretroviral: Ten-Day Clinical Trial Results

• Issue #412, July 31, 2005
  1. Campaign to End AIDS (C2EA) -- New National Mobilization

• Issue #411, June 20, 2005
  1. Tipranavir (Aptivus): Approval Cautiously Recommended
  2. ADAP Status Now: What You Can Do
  3. Medicaid: Out-of-Pocket Expenses and Access to Care
  4. Lexiva: Blood Levels Not Lowered When Taken Simultaneously With Nexium
  5. New Conference for Frontline Clinicians, September 15-18
  6. Medical Innovation Prize Fund: New Idea in Drug Development
  7. Medical Innovation and Patent Gridlock

• Issue #410, May 6, 2005
  1. Involuntary Weight Loss: Interview With Lisa Capaldini, M.D.
  2. Medicaid Cuts Alert
  3. Adult HIV Treatment Guidelines Updated
  4. In-Depth Medical Reports on the Retroviruses Conference
  5. IOM: Nevirapine Study Is Reliable
  6. DHEA Access Threatened?

• Issue #409, April 8, 2005
  1. HIV Travel Restrictions: Where to Find Help Navigating Them
  2. Tipranavir: FDA Advisory Committee Will Meet May 19, Hear Experts, Public Comment
  3. Sculptra Facial Treatment: New Physician Locator
  4. FDA AIDS Announcements, First Quarter 2005
  5. Uganda Study Found That Death Reduced HIV Prevalence; Did the Public Take Home the Wrong Message?
  6. Virginity Pledge Did Not Prevent Sexually Transmitted Infections
  7. Prison Health Care: New York Times Series Brings Attention

• Issue #408, February 28, 2005
  1. Kidney, Liver Transplant Study for People With HIV
  2. HIV "New Strain" Story: For More Information
  3. HIV: More Voluntary Testing Recommended
  4. Early Medicaid Treatment: Bipartisan Bill in Senate With 32 Cosponsors, Could Cut HIV Deaths on Medicaid in Half
  5. Tat Inhibitors, A New Approach: Interview With Olaf Kutsch, Ph.D.
  6. If the Condom Breaks: New U.S. Guidelines for Non-Occupational Exposure to HIV
  7. Global Good News: Many More Treated
  8. FDA Advisory on Nevirapine
  9. Conferences and Meetings Calendar, 2005

2004

• Issue #407, December 31, 2004
  1. Nevirapine Misinformation: Will It Kill?
  2. Behind "AIDS Breakthrough" Headlines, December 2004: Important Research, Not So New
  3. Warning: Do Not Combine Reyataz and Prilosec
  4. India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries
  5. Africa: Children's Access to Prophylaxis May Improve After Medical Study, New WHO Recommendations
  6. Treatment Interruption: Most Patients Could Not Maintain Immune Control
  7. Retroviruses Conference Reminder: You Must Complete Housing Process to Attend
  8. Weekend Treatment Interruptions for Certain Well-Controlled Patients: Interview With Cal Cohen, M.D.
  9. Sculptra (Formerly New Fill) for Facial Wasting -- Where to Find Information on the Patient-Assistance Program
  10. Buyers' Club List, December 2004

• Issue #406, November 23, 2004
  1. Saving AIDS Conferences Online: Interview with Sister Mary Elizabeth, Founder of AEGiS
  2. Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune
  3. New Treatment Guidelines Published October 29
  4. Retroviruses Conference: Community Deadlines, Nov. 23
  5. World AIDS Day, December 1: Women and Girls
  6. Prison Health Care: Activist Campaign Targets Hepatitis, HIV Care for Prisoners and Continuity of Care After Release
  7. After the Election

• Issue #405, October 26, 2004
  1. New Fixed-Dose Once-a-Day Starting Regimens: Interview With Cal Cohen, M.D.
  2. Depression: Louganis and Allen to Speak at Forums in New York and San Francisco Oct. 27
  3. Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
  4. Kaletra Monotherapy Controversy: amfAR Publishes Overview
  5. Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004

• Depression: Louganis and Allen to Speak at Forums in New York, San Francisco (October 8, 2004)

• Issue #404, September 15, 2004
  1. ADAP Activists Needed in All U.S. States and Territories
  2. ACT UP: Enormous Worldwide Attention to New York Demos
  3. Medical Information From Bangkok Conference: Clinical Care Options Site
  4. AIDSVote: Election Information and Activism
  5. Elections: Widespread Misinformation on Who Can Vote
  6. Nutrition: Call for Information -- What Has Been Most Helpful to You?
  7. Medical Marijuana Rescheduling Rally, Washington DC October 5
  8. Empty Antibiotic Pipeline Critically Endangers Public: IDSA Report
  9. Clinical Trials: Philadelphia Hospitals Combine to Form "Supersite" and Reduce Delays
  10. AIDS Treatment and Related Conference Calendar (Starting September 2004)

• Issue #403, August 23, 2004
  1. Chronically Depressed Women With HIV Almost Twice as Likely as Others to Die From AIDS-Related Causes; Those With Mental-Health Services Had Half the Death Rate of Those Without
  2. Cambodia Stops Important Tenofovir Prevention Trial
  3. Hepatitis Coinfection: Two Major Studies Published
  4. FDA Approves Two Combination Pills, Epzicom and Truvada; Comment on Commercial Race to Once-a-Day Nucleosides
  5. Smarter Clinical Trials for Faster Drug Development
  6. Retroviruses Conference Date Set
  7. HIV Treatment and Immunology Research: Current Ideas

• Issue #402, June 30, 2004
  1. Bangkok Conference, July 11-16; Getting News Online
  2. U.S. Researcher Starts Treatment Fund in Uganda: Interview With David Bangsberg, M.D., M.P.H.
  3. President Bush on AIDS: More Questions Than Answers
  4. Abstinence, Abstinence-Only, Faith-Based, and the Psychology of Stigma
  5. Medical Marijuana: Important Vote Coming, You Can Help
  6. ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
  7. Drug Resistance Workshop (June 2004) Summaries Available

• Issue #401, June 12, 2004
  1. New Medicare-Approved Prescription Drug Discount Card
  2. Institute of Medicine Urges Restructuring of U.S. Low-Income HIV Treatment and Care
  3. ADAP Crisis National Call-In Alert, Starting June 14
  4. Inexpensive Air Filter for Allergy Relief
  5. Grants for Innovative Treatment, Vaccine or Microbicide Research, Application Deadline July 31
  6. Bangkok AIDS Conference May Be Largest Ever, July 11 to 16
  7. Ronald Reagan Remembered

• Issue #400, May 18, 2004
  1. TMC-125: Important One-Year Trial Now Recruiting in U.S.
  2. Gonorrhea: New Treatment Recommendations for Gay Men, MSM
  3. May 20: "Time's Up!" AIDS Protest in Washington D.C.
  4. How to Network Action Alerts, So That Others Can Help
  5. Online Glossaries of HIV/AIDS Terms
  6. Checking Your Drug Interactions

• Issue #399, March 26, 2004
  1. Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
  2. Atherosclerosis Risk Increased With HIV; Treatment Effects Unclear
  3. Atazanavir (Reyataz): New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
  4. Abacavir Hypersensitivity Reaction Predicted by Genetic Test
  5. Update on Sculptra (New-Fill) Hearing
  6. Lessons From Two
  7. Retroviruses Conference: Summaries for Physicians
  8. Medicines for the World: A Way Forward

• Issue #398, February 27, 2004
  1. Antiretroviral Pipeline: New-Drug Reports from Retroviruses Conference
  2. FDA Advisory Hearing on New-Fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland
  3. Lipodystrophy: Conference on Imaging Technologies in Clinical Management, Montreal, April 2-3, 2004
  4. Micronutrient Supplementation Shows Promise in Placebo-Controlled Trial
  5. Nevirapine Precautions Published
  6. Prison HIV and Hepatitis C Sites
  7. "Poppers," Some Other Drugs, May Increase HIV Infection Risk
  8. New Testing for Very Early HIV Diagnosis
  9. No January 2004 Issue of AIDS Treatment News
  10. Improving AIDS Conferences With Online Information

2003

• Issue #397, December 26, 2003
  1. "Shy" Study Suggests New Treatment Mechanism
  2. Abbott Laboratories Increases Norvir Price Fivefold
  3. ADAP Washington Visit Feb. 23-25; Scholarship Deadline January 16
  4. African-Americans and AIDS Conference, Philadelphia, Feb. 23-24
  5. AIDS Treatment News Will Publish Online, Print 12 Issues a Year
  6. Buyers' Club List, December 2003
  7. AIDS Treatment News Index, 2003

• Issue #396, November 28, 2003
  1. World AIDS: $4.7 Billion -- WorldCom: $35 Billion
  2. UNAIDS Report for 2003: Most Deaths and New Infections Ever; Some Good News
  3. New Neuropathy Treatment Guidelines
  4. Revised U.S. Adult and Adolescent Antiretroviral Treatment Guidelines; Also Revised Pediatric Guidelines
  5. AIDS Treatment News: Changes Next Year
  6. Subscriptions to Share: New Way to Sell Content or Help Fundraising Online

• Issue #395, October 31, 2003
  1. Lexiva (Fosamprenavir) Approved
  2. Warning Against Once-Daily Tenofovir+ddI+3TC, and "Triple Nuke" Combinations
  3. Clinton Foundation Gets Big Price Reduction -- to 40 Cents a Day for Three-Drug Combination
  4. Retroviruses Conference Reminder: Community, Press Deadlines November 14
  5. Thailand International Conference Submission Deadlines (Theme: Access for All)
  6. Clinical Trials Forum: World AIDS Day (December 1), Boston
  7. Returning to Work After Disability: What You Should Know

• Issue #394, September 12, 2003
  1. WTO Accepts Rules Limiting Medicine Exports to Poor Countries
  2. Nevirapine Reduced Mother-to-Child Transmission Better Than AZT -- At 70 Times Less Cost
  3. Treatment Interruption: Study Found Poor Result for Highly Treated, Highly Resistant Patients
  4. New Guidelines for Avoiding Heart Disease by Managing High Cholesterol, Triglycerides, or Related Problems in HIV

• Issue #393, July 25, 2003
  1. Failure of Combination Abacavir + Tenofovir + Lamivudine (3TC)
  2. FTC (Emtriva) Approved
  3. New HIV Treatment Guidelines Give More Advice
  4. HIV Drugs Approved as of August 2003
  5. Major HIV Treatment Conference in Paris -- Finding Reports Online
  6. Nelson Mandela on Treatment Access

• Issue #392, June 27, 2003
  1. Major Scientific AIDS Conference, Paris July 13-16; Reports Online
  2. New Protease Inhibitor Atazanavir (Reyataz) Approved
  3. Federal AIDS Policy Emergencies
  4. AIDS, Computers, and Organizing: Part I, Toward a Revolution in Fundraising? A Report From the Planetwork Conference

• Issue #391, May 30, 2003
  1. Bush Signs Global AIDS Bill
  2. HIV Nutrition Papers Published
  3. Atazanavir Background Documents Available
  4. First Clinical Care Options for Hepatitis, June 19-22
  5. Surprising Causes of Death in Texas Hospital Study: Safety Net Questions
  6. Glaxo Drug Discovery and Development Research Grants (Including Microbicides); Deadline July 31
  7. Africa: Problems Getting Antiretrovirals for Trials
  8. Funding Alert: Wake Up and Support WORLD
  9. Huge Price Variations in Generic Drugs
  10. Philadelphia: June Is AIDS Education Month

• Issue #390, April 4, 2003
  1. Treatment Interruption; Advanced HIV; New Ideas: Dr. Cal Cohen Interview on Retroviruses Conference (Part 2 of 2)
  2. SARS Web Information
  3. Abacavir Arm Stopped in Clinical Trial
  4. Huge Medicaid Cuts Weighed in Washington
  5. Africa Activism: Money for AIDS Not for War; South Africa Antiretrovirals
  6. Prison Health News First Issue Available

• Issue #389, March 14, 2003
  1. Retroviruses Conference Clinical News: Interview With Cal Cohen, M.D.
  2. First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads
  3. T-20: Most Expensive AIDS Drug Ever at $25,000 Per Year?
  4. Clinton Team Lowers Drug Price Seven-Fold in Caribbean
  5. Help Wanted: Treatment Information and Advocacy at Project Inform, Spanish Bilingual Preferred
  6. Warning, Counterfeit Procrit (Epoetin Alfa)

• Issue #388, February 7, 2003
  1. Antibiotic-Resistant Skin Infections Spreading Among Gay Men, Also in Prisons
  2. Retroviruses Conference, Feb. 10-14; Sites to Watch for News
  3. Building Grassroots Support for AIDS
  4. Bush Proposes Near Tripling of U.S. Commitment on Global HIV Epidemic
  5. African-Americans and AIDS, Conference Feb. 24 and 25, New York

2002

• AIDS Treatment News Index, 2002

• Issue #387, December 27, 2002
  1. ADAP and Medicaid Financial Emergencies Growing
  2. Smallpox Vaccination Followup: IOM Suggests Changes, Widespread Civilian Vaccinations to Begin
  3. Boston: Community Forum on Retroviruses Conference, Feb. 14
  4. AIDS Treatment News Backdated for This Issue
  5. Buyers' Club List, December 2002
  6. AIDS Treatment News Index, 2002

• Issue #386, December 20, 2002
  1. Smallpox Vaccination Begins in U.S. -- Precautions Needed
  2. U.S. Blocks Trade Agreement on Generic Drug Access in Poor Countries
  3. Tenofovir (Viread®) Access for Poor Countries
  4. ADAP Crisis: Sign-On Letter for Organizations, Before January 6 If Possible
  5. Retroviruses Conference: Caution, January 10 Housing Deadline; Registration Still Open
  6. New Government AIDS Web Site, Phone Number

• Issue #385, November 22, 2002
  1. New Guidelines on Metabolic Complications of HIV and Antiretroviral Treatment
  2. Nevirapine Patient Assistance Program: Model for Better Administration?
  3. Heart-Disease Risk and C-Reactive Protein
  4. Vaccine Against Three Kinds of HIV Begins Human Tests
  5. Prevention: New Approach Will Test Tenofovir for Persons at High Risk
  6. U.S. AIDS Research Needs Tissue Donations
  7. Call for U.S. Action on AIDS, Washington, D.C., November 26
  8. Drug Patents and Developing Countries: Problems Remain
  9. Marijuana Lung Health Report: Less Than Meets the Eye?

• Issue #384, October 18, 2002
  1. Animal Retroviral Infections Suggest Third Kind of Potential Treatment: HIV Harm Reduction
  2. T-20 (Fuzeon) Gets Priority Review
  3. ICAAC Clinical Trials Review Available
  4. Hepatitis C: FDA Public Meeting on Peginterferon Plus Ribavirin, Nov. 14
  5. Anti-HIV Factor Discovered
  6. Retroviruses Scholarship, Community Press, Other Deadlines Soon
  7. Treat-Your-Workers.org; International Coca-Cola Protest October 17
  8. Chinese AIDS Activist Released
  9. Nonoxynol-9 Dangers: Health Experts Warn Against Rectal Use

• Issue #383, September 6, 2002
  1. HIV Medicine After Barcelona Conference: Interview With Howard Grossman, M.D.
  2. Pan-African AIDS Treatment Movement Launched
  3. Chinese Activist Detained by Police, Immediate Action Needed
  4. Philadelphia, New York: Dr. Jon Kaiser's Treatment Update, September 17, 18

• Issue #382, August 9, 2002
  1. Barcelona Conference: New Online Report
  2. Barcelona Conference: Daily News Links
  3. ACTG 384 at Barcelona: The Bottom Line
  4. Nandrolone: Generic Now in Stock
  5. "Save ADAP" Campaign Starts August 12 -- What You Can Do Now
  6. National AIDS Treatment Advocates Forum (New Orleans, December 2002)
  7. Barcelona Comments

• Issue #381, June 28, 2002
  1. Nonoxynol-9 Harmful, Should Not Be Used in Condoms, Lube
  2. Barcelona International Conference, July 7-12 -- Web Sites to Watch
  3. Nandrolone (Deca Durabolin) Disappears in U.S., Generic May Return in July
  4. Barcelona: Visa Barriers May Disrupt Conference
  5. Thousands Face Loss of Treatment in ADAP Money Crisis
  6. On an ADAP Waiting List? Advice from Treatment Activists

• Issue #380, May 31, 2002
  1. Treatment Access Emergency: ADAP and Medicaid
  2. AIDSWatch Congressional Lobbying, June 9-11 in Washington
  3. Counterfeit Drugs: Check Combivir, Serostim, Epogen
  4. Medicaid Funding Cuts Affect People With AIDS Across the U.S.
  5. Johns Hopkins HIV Treatment Short Guide
  6. Remune Controversy Articles
  7. Philadelphia: AIDS Education Month Talks and Programs

• Issue #379, April 12, 2002
  1. Retroviruses Conference: Some New Drugs in the Pipeline
  2. Measles Found to Suppress HIV
  3. New Cancer Drugs Might Help Treat HIV -- But Research Not Done
  4. Bone Problems: Overview Article Available
  5. Alert: International Epidemic, Disease Control
  6. Medical Privacy Rule Changes: Public Comments Due April 26
  7. Medical Marijuana Action Alert

• Issue #378, March 8, 2002
  1. Retroviruses Conference Reassuring on New Treatments, Viral Targets, Research
  2. Lipoatrophy and Antiretroviral Drug Changes
  3. Retroviruses Conference: Web Coverage
  4. d4T and Lactic Acidosis With Neuromuscular Weakness: FDA Warning
  5. FDA Approves New Dosing for Amprenavir and Ritonavir Combination
  6. FDA Approves Once-Daily Efavirenz Formulation, Revised Labeling
  7. AIDS Treatment and Related Conferences, March Through December 2002

• Issue #377, January 25, 2002
  To read PDF, click here
  1. 2002 Overview: The Role of Activism
  2. Heart Disease Prevention
  3. Drug Interactions Need More Attention
  4. More Uses for Tenofovir?
  5. New Kinds of Treatment
  6. Legal/Medical Issues
  7. Drug Pricing
  8. Improving Activism
  9. Improving Fundraising
  10. Funding Medical Research and Drug Development
  11. Diet and Inflammation? (Personal Note)

2001

• AIDS Treatment News Index, 2001

• Issue #376, December 28, 2001
  To read PDF, click here
  1. HIV Resistance: Data and Spin
  2. Barcelona Conference Abstract, Scholarship Deadlines Early 2002
  3. African-Americans and AIDS Conference, February 25-26, Washington
  4. AIDS Treatment News Denialist Series
  5. Medical Marijuana Grants: Application Deadlines January 15, May 1, and September 1
  6. Buyers' Club List, December 2001
  7. AIDS Treatment News Index, 2001

• Issue #375, December 21, 2001
  To read PDF, click here
  1. Garlic Reduces Saquinavir Blood Levels 50%; May Affect Other Drugs
  2. NIH Seven-Day On-Off Trial May Reduce Drug Side Effects, Cost; Why It's Not Ready for Use
  3. AIDS and Hepatitis News from ICAAC Conference: Phone Overview, Web Reports
  4. HIV Testing 101 (Part 2 of 2)
  5. AIDS Treatment News New Publication Schedule

• Issue #374, November 23, 2001
  To read PDF, click here
  1. Viral Load: Small Change by Sixth Day of Treatment Can Often Predict Poor Response
  2. New Resistance Test Combines Phenotype and Genotype
  3. Protease Inhibitors in Children: Combination Therapy Reduced Death by Two Thirds
  4. South Africa: Activists, Physicians Sue Government to Prevent Maternal Transmission, Ask International Support
  5. HIV Testing 101 (Part 1 of 2)

• Issue #373, October 26, 2001
  To read PDF, click here
  1. Tenofovir Approved: Broad Indication
  2. T-20 Small Program, CD4 <50, Will Enroll November 27 at 3:00 P.M.
  3. Treatment News from Recent Conferences: Finding Web Reports
  4. Anthrax, Bioterrorism Fears Stimulate Immune, Other Research
  5. Africa: Funding Sought for Epidemic Control
  6. World AIDS Day Web Page

• Issue #372, October 19, 2001
  To read PDF, click here
  1. Tenofovir: FDA Hearing on Important New Antiretroviral
  2. Apparently Harmless Virus Associated with Reduced HIV Death
  3. Retroviruses Conference: Major Deadlines November 16, 2001
  4. Barcelona International Conference, July 7-12, 2002: Time to Start Planning
  5. "A Day for Women" Medical Information Meeting, November 3 in New York
  6. New HIV Drugs: Extensive Lists, Additional Information
  7. Africa Access News

• Issue #371, September 21, 2001
  To read PDF, click here
  1. September 11: What Happens Now?
  2. Tuberculosis: Guidelines Changed for Latent TB Treatment
  3. HIV/HCV Coinfection: One-Day Conference October 11 in Washington
  4. amfAR Announces Research Grants: Letters of Intent Due October 23
  5. ICAAC Postponed to December 16-19; "Salvage" Workshop Also Postponed
  6. ADAP Funding Crisis: Talking Points
  7. U.S. and Switzerland Oppose Developing-Country Proposal on Access to Medicines
  8. AIDS Treatment News Publication Schedule
  9. Malawi Plan to Control AIDS Epidemic: Interview with David Scondras of Search for a Cure

• Issue #370, August 24, 2001
  To read PDF, click here
  1. Liver Fibrosis in HIV/Hepatitis C Coinfection: HIV Protease Inhibitors May Be Protective
  2. Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26
  3. Homocysteine, HIV and Heart Disease
  4. AIDS Treatment Activists Form New Coalition
  5. Action Alert: Global AIDS Funding
  6. NATAF Scholarship Deadline August 31; You Can Apply Online

• Issue #369, July 27, 2001
  To read PDF, click here
  1. Global Epidemic, U.S. Response: A Winning Strategy, What You Can Do
  2. Treatment Interruption: Erroneous Press Report
  3. Vaccines: Major Conference Sept. 5-8 in Philadelphia
  4. IAS Buenos Aires Conference: Medscape CME Summaries
  5. FDA: New Email List on HIV/AIDS
  6. Science Project Director Wanted -- Treatment Action Group (TAG)

• Issue #368, July 13, 2001
  To read PDF, click here
  1. Buenos Aires Conference on Treatment and Research: Web Reports Available
  2. AIDS Research Today: 20 Views
  3. Africa: Interview with South African High Court Justice Edwin Cameron
  4. HIV Resistance Meeting Web Reports
  5. Women's HIV Treatment Issues: Course for Medical Professionals, July 26-27

• Issue #367, June 29, 2001
  To read PDF, click here
  1. AIDS Vaccines and Activism: Interview with Jon Cohen
  2. United Nations AIDS Meeting: Observations
  3. Global AIDS Epidemic: Getting Things Done
  4. Names Reporting: Pennsylvania, California Activists Change the Momentum

• Issue #366, June 23, 2001
  To read PDF, click here
  1. United Nations: Special AIDS Session Next Week
  2. Drug Patents and Developing Countries: New Proposal
  3. Bone Disease: Report on the Web
  4. Mitochondrial Toxicity: Report on the Web
  5. ADAP (AIDS Drug Assistance Program) Funding: Action Needed

• Issue #365, May 25, 2001
  To read PDF, click here
  1. Antibodies and HIV: New Evidence (Interview with Ruth Ruprecht, M.D., Ph.D.)
  2. Danger: Counterfeit Neupogen® (Filgrastim)
  3. Danger: Counterfeit Serostim® (Human Growth Hormone)
  4. June 23: New York March and Rally Before United Nations AIDS Session
  5. United Nations: Civil Society Snubbed at Final Preparatory Meeting on AIDS
  6. Global AIDS: Back to the Past?

• Issue #364, May 11, 2001
  To read PDF, click here
  1. Tenofovir: Gilead Applies for Approval; Expanded Access Liberalized
  2. June 3 Demonstration in Washington to Mark 20th Year of AIDS
  3. International AIDS Candlelight Memorial, May 20
  4. Updated Guidelines for Prevention of Mother-to-Infant Transmission
  5. Syringe Prescription Study Unexpected Bonus: Helping Long-Time Users Quit Drugs
  6. TAG Seeks Policy Director
  7. South African Court Case -- Documents on the Web
  8. AIDS Treatment News Publication Schedule: No Issues Dated April 2001
  9. Viral Load and T-Cell (CD4) Counts: Why They Matter

• Issue #363, March 30, 2001
  1. Africa Access: AIDS Activists Organizing Burkina Faso Summit on Generics
  2. European Parliament Supports Treatment Access in Developing Countries
  3. Therapeutic Drug Monitoring: Medscape Web Resource Page
  4. amfAR Treatment Directory: How to Obtain a Free Copy
  5. Twinning U.S. and African AIDS Organizations: NMAC Training in U.S. Cities
  6. Barcelona 2002: International AIDS Conference Seeks Scientific Program Coordinator

• Issue #362, March 23, 2001
  1. Building Alliances for World Health Funding
  2. FDA Gives Salvage Therapy Testing a Push Forward
  3. AIDSWatch May 5-8: Visit Your Representatives in Washington
  4. amfAR HIV/AIDS Treatment Directory Available
  5. AIDS Treatment News Publication Schedule

• Issue #361, February 28, 2001
  1. Retroviruses Conference: Johns Hopkins Report
  2. Obtaining the New HIV Treatment Guidelines
  3. Merck, Bristol-Myers Squibb Announce Major Price Reductions for Poorest Countries: Major Access Progress but Questions Remain
  4. MSF (Doctors Without Borders) Petition Against South Africa Lawsuit, Deadline April 15
  5. Southern Africa Home Care: Conference Report
  6. amfAR Seeks Medical Writer/Editor in New York

• Issue #360, February 23, 2001
  1. Tenofovir DF Expanded Access
  2. New Immune-Based Treatment Approach: Trial Recruiting in San Francisco
  3. Africa Access: Moving Fast, Outcome Uncertain
  4. South Africa Lawsuit: March 5 Worldwide Protest Information
  5. AIDS Treatment News Publication Schedule, February-March 2001

• Issue #359, January 26, 2001
  1. Retroviruses Conference: Live Telephone Report Feb. 7
  2. First HIV Vaccine for Africa Begins Trials
  3. African Americans and AIDS Conference, Feb. 19-20, Washington, D.C.: Fauci, Gayle, Primm, Other Speakers
  4. United Nations AIDS Session: Email Input Sought
     
  5. March 5: "Global Day of Action Against Drug Company Profiteering," as Pharmaceutical Companies Sue South Africa to Block Low-Cost Medicines
  6. Africa Treatment Access: Contact President and Congress on Africa Executive Order
  7. News Flash: Brazil; South Africa Lawsuit Letter
  8. Hepatitis C, Co-Infection Information Recommended
  9. AIDS Treatment News Contacts, Schedule Update
  10. San Francisco Data Show HIV Rates Still Rising, Experts Say

• Issue #358, January 12, 2001
  1. AIDS Treatment News New Philadelphia Contacts
  2. AIDS Treatment Fact Sheets: Interview with Bob Munk, New Mexico AIDS InfoNet
  3. Urgent, United Nations AIDS Session, Deadline February 1, Email Input Any Time
  4. Nevirapine Warning on Post-Exposure Prophylaxis
  5. d4T plus ddI: Warning for Pregnant Women

2000

• AIDS Treatment News Index, 2000

• Issue #357, December 22, 2000
  1. European Jewish Ancestry: Activist Doctor Needs Stem Cell Donation
  2. University of California AIDS Research: Conference February 16, Los Angeles
  3. Help Wanted: Executive Director, Washington D.C.
  4. Medicine Recycling: List of Donation Centers Published December 2000
  5. Buyers' Club List, December 2000
  6. AIDS Treatment News Index, 2000

• Issue #356, December 1, 2000
  1. Structured Treatment Interruption: Important Controlled Trial in Monkeys
  2. Superinfection (Reinfection): New Study in San Francisco Offers Free Resistance and Viral Load Testing
  3. New Report on World AIDS Epidemic
  4. Global Treatment Access: Call for 95% Price Reduction; New GTAC Organization Web Site
  5. California: MediCal Income Eligibility Level Raised for the Disabled and Aged
  6. Answering the AIDS Denialists: Is AIDS Real?

• Issue #355, November 17, 2000
  1. Community Update: New Drugs to Watch
  2. Nevirapine (Viramune®) Strengthens Warning on Liver, Skin Toxicities
  3. "Trizivir" Approved: Three Existing Drugs in One
  4. Nutrition and HIV Infection: Experience in Zimbabwe -- Interview with Lynde Francis
  5. AIDS Treatment News Will Move to Philadelphia on January 2

• Issue #354, November 3, 2000
  1. Enteric-Coated ddI Approved: FDA Letter
  2. Retroviruses Conference: Registration Deadline for Community Attendance is Nov. 17
  3. Durban Conference Searchable Abstracts Now Available on Web
  4. Bitter Publication Dispute on Remune Study: More Than Meets the Eye?
  5. Many People with HIV/AIDS Not Getting Proper Treatment
  6. Flu Shot Time: Vaccine Shortage in Many Areas
  7. Help Wanted: AIDS Writer for AmFAR in New York
  8. AIDS Treatment News Price Increase January 1; Act Now to Renew at Current Rate
  9. HIV Treatment and Survival: Easy Language Version
  10. Has Anti-HIV Treatment Cut AIDS Deaths?

• Issue #353, October 20, 2000
  1. Vaccine Advance: Monkeys Still Infected, but Protected from Illness
  2. FDA Meeting on Approving Immune Therapies: Background and Comment
  3. South Africa: Historic "Defiance Campaign" Imports Generic Fluconazole
  4. Congress Considering Medicaid Coverage for Persons with HIV: Call Your Representatives
  5. HMOs, Health Insurance: More Problems

• Issue #352, October 6, 2000
  1. NAC Update Issue: New Information
  2. NAC: Stanford San Francisco Study Report Shows Blood Glutathione Improvement, Possible Survival Benefit
  3. NAC and Glutathione: Recent Publications

• Issue #351, September 22, 2000
  1. Kaletra (ABT-378/r) Approved
  2. New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment
  3. Immune-based Therapies: FDA Meeting October 16
  4. ICAAC, Lipodystrophy, IDSA: Conference Summaries on Web
  5. 2001 Retroviruses Conference, Chicago: Deadlines Start in October
  6. Brazil AIDS Success: Washington Post Report
  7. Critical Path Newsletter: Kiyoshi Kuromiya Memorial, Prison Resources
  8. Treatment and Survival Special Issue: How to Reprint for Clients

• Issue #350, September 8, 2000
  1. A Word from John James on this Special Issue on Treatment and Survival
  2. AIDS Treatment Improves Survival: Answering the "AIDS Denialists"
     • Introduction
     • "Die Offs" and "Shocking Statistics"
     • What the Cohort Studies Say
     • Local Studies with All HIV/AIDS Patients
     • The "Drug-AIDS" Hypothesis
     • References

• Issue #349, August 18, 2000
  1. Scrub Typhus: Infection Reduces Viral Load in Some Patients
  2. ICAAC Research Conference: Free Telephone Summary September 19
  3. Global Resistance Day, September 16, Toronto
  4. Health Insurance Reimbursement Legislation
  5. Prevention: Changing Focus in San Francisco
  6. Oakland, California: HIV Drug Resistance Talk, August 31
  7. Kaletra(TM) (ABT-378/r) Early Access Program Can Accept More Patients
  8. ICAAC, September 17-20 in Toronto
  9. Viral Hepatitis Summit for San Francisco Area Organizations
  10. Side Effects, Lipodystrophy: Free Telephone Conference September 15
  11. United States Conference on AIDS, Atlanta, Georgia, October 1-4
  12. ACT UP/Philadelphia Arrest Followup

• Issue #348, August 4, 2000
  1. Philadelphia Protests: National Support Needed
  2. Marijuana Safety Study Completed: Weight Gain, No Safety Problems
  3. Other Medical Marijuana News
  4. Medicine Recycling to Latin America: Interview with Jesús Agüais, AID for AIDS in New York
  5. Ziagen(R) (Abacavir): New Warning on Restarting

• Issue #347, July 28, 2000
  1. Weekly Intermittent Treatment: Caution
  2. Selenium: Important New Review of Health Findings
  3. Access to Treatment Worldwide: From Talk to Action at Durban
  4. Selenium: African Studies Reported at Durban
  5. "HIV" Controversy: Nelson Mandela's Call to End Dispute

• Issue #346, July 7, 2000
  1. Durban Conference: Official Webcast
  2. Durban Conference: Teleconference Summary July 20
  3. Durban Declaration on HIV and AIDS
  4. San Francisco Statement on HIV and AIDS
  5. Communication Skills and HIV Prevention
  6. Tuberculosis: New Drug Class Investigated through Public-Private Partnership
  7. HMO, Insurance Policies Threaten HIV Care: Interview with Dr. X

• Issue #345, June 23, 2000
  1. Kaletra(®) (ABT-378/r) Application for Accelerated Approval
  2. Durban World Conference, July 9-14: Online Coverage
  3. HIV/AIDS Clinical Update Published on Web
  4. HIV Drug Resistance Meeting: Reports on Web
  5. Bone, Hip Problems: Overview Article Online
  6. A No-Nonsense Guide to HIV Drug Resistance Testing Booklet
  7. Excellent Book on Gay Men's Health
  8. Urgent: South African Treatment Activists Need Assistance
  9. Durban: Global Call for Treatment Access
  10. Durban and South Africa Travel, Phone Tips
  11. FDA Public Meeting on Pharmacokinetics and Antiviral Response, July 25 near Washington D.C.

• Issue #344, June 2, 2000
  1. Treatment Interruption: Free Telephone Conference Call June 20
  2. New Oral DNA Vaccine Funded for Trials
  3. Frequent Urination, Leg Cramps, Leg Weakness, Erection Difficulties: HIV Myelopathy Amino Acid Study
  4. Clinical Trials and Industry Influence: Major Report
  5. "Mental" Issue Threatens Medical Care
  6. World Issues Today: Interview with Peter Piot, Executive Director of UNAIDS
  7. Global Health Council 2000 Conference, June 14-16 Near Washington

• Issue #343, May 19, 2000
  1. Africa Treatment Access in the News
  2. Africa Access: Call for Information
  3. Resistance Testing Recommended in New IAS -- USA Guidelines
  4. San Francisco: Misdemeanor Charges in Treatment Meeting Disruption
  5. Durban Conference Status, May 2000: Interview with Conference Chair Coovadia
  6. Endorsements Sought for Global March for HIV/AIDS Treatment, July 9, Durban
  7. Kiyoshi Kuromiya, 1943-2000

• Issue #342, May 5, 2000
  1. AIDS Declared National Security Threat
  2. Conference Call on New Drugs and Strategies, May 23
  3. Amprenavir (Agenerase®) Oral Solution: Warning for Some Patients
  4. Nevirapine (Viramune): European Warning
  5. Efavirenz (Sustiva®): Oral Liquid Expanded Access Program for Children and Adolescents Ages 3-16
  6. Retroviruses Conference: New Printed Summary
  7. Prison and HIV or Hepatitis: June 17 Meeting in Washington
  8. AIDS Candlelight Memorial, May 21
  9. South Africa: Advisor Ian Roberts Resigns
  10. AIDS Denialists: How to Respond

• Issue #341, April 21, 2000
  1. Treatment Interruption: Experts Sound Cautious Note at San Francisco Forum; Meeting Proceeds Despite Disruption
  2. Answering the AIDS Denialists: CD4 (T-Cell) Counts, and Viral Load
  3. ACT UP Golden Gate Changes Name to Survive AIDS
  4. Vaccines: Call Congress to Support R&D Tax Credit
  5. Africa Series Wins Pulitzer
  6. Treatment Fact Sheets: Call for Information
  7. Sign-On Statement Against U.S. Drug-Price Increases

• Issue #340, April 7, 2000
  1. AIDS Practice Issues Today
     Interview with Paul Bellman, M.D.
  2. South Africa "AIDS Dissident" Dispute: Time to Stop and Think
     
  3. Pfizer Will Donate Fluconazole to South Africa
     
  4. New York: Immune-Based Therapies Teach-In, April 15

• Issue #339, March 17, 2000
  1. Treatment Models from India
     Interview with Shashank Joshi, M.D
  2. Testosterone Cream Available at CPS; Gel Approved by FDA
  3. Anabolics, Exercise, Nutrition, Supplements: New Book Available
  4. Vaccine News, March 2, 2000
  5. Fluconazole: Pfizer Asked to Lower Africa Price
  6. Dietary Supplement Regulation: FDA Public Hearing April 4, Written Comments Due May 4
  7. FDA Drug-Approval Background: New Web Pages
  8. African-Americans and AIDS: Highlights of 2nd Annual Washington Conference

• Issue #338, March 3, 2000
  1. HAART and Medical Management: The Realities of Clinic Care
     Interview with Keith Henry, M.D.
  2. National AIDS Update Conference March 14-17, San Francisco
  3. First Microbicide Conference March 13-16, Near Washington D.C.

• Issue #337, February 18, 2000
  1. A Call for More Cautious Antiretroviral Treatment
  2. St. John's Wort Warning: Do Not Combine with Protease Inhibitors, NNRTIs
  3. New Guidelines for HIV Treatment; Resistance Testing Now Recommended
  4. HIV Resistance-Testing Information on Web
  5. Abacavir Warning: Certain Respiratory Symptoms Can Indicate Hypersensitivity Reaction

• Issue #336, February 4, 2000
  1. Retroviruses Conference: Overview, Information Available
  2. San Francisco: Retroviruses Conference Community Forum, Feb. 17
  3. Testosterone, Other Injectable Drug Access Problems in San Francisco Area: Call for Information
  4. Large Cuts in Public Hospital, Clinic HIV Services, San Francisco and National -- Why?

• Issue #335, January 21, 2000
  1. Flu Epidemic: Shots, New Treatments Available
  2. Liver Toxicity, Ritonavir, and Hepatitis C: New Data Published
  3. Post-Exposure Prevention (PEP) for Sexual, Needle Exposure Opens in New York
  4. African-Americans and AIDS Conference, February 24-25, Washington D.C.
  5. Retroviruses Conference, January 30 - February 2
  6. Reminder: Durban Conference Deadlines February 1

• Issue #334, January 7, 2000
  1. 2000 Outlook
  2. Retroviruses Conference Report by Telephone Conference, February 2
  3. Lipodystrophy Report by Telephone Conference, February 9
  4. Three Activist Meetings, San Francisco, Late January
  5. Neuropathy: Practical Book on Mainstream, Alternative Options
  6. Acupuncture Detoxification Meeting, San Francisco, January 28 and 29
  7. Disability Benefits: New Law Will Help Disabled Return to Work